Authors: M. Asif Durrani, Saleem Ahmed Kharal Jawed Ahmed Badvi, Amtul Hafiz
Abstract
Hepatitis C is a major cause of non-A, non-B viral liver disease through out the world in haemophilic patients. There is an urgent need to eliminate HCV from clotting factor concentrates by screening and other means; only when this has been achieved would it be possible to determine whether other agents cause chronic liver disease in patients with hemophilia. There have been many studies from Pakistan using prevalence of hepatitis C in chronically transfused patients (thalasemics, dialysis patients, blood donors and general population), but there has been no published study from Pakistan stating hepatitis C prevalence in haemophilic patients. OBJECTIVE : This study was planned to see the prevalence of hepatitis C antibodies in haemophilic patients and its association with raised ALT (Alanine Aminotransferase) as a surrogate marker for hepatitis. PATIENTS AND METHODS: Sera of eighty haemophilic patients registered and treated at JPMC and Fatmid center, Karachi were collected along with 20 control subjects and analyzed for hepatitis C antibody by Abbott HCV EIA 3.0 Kit. ALT was also done on all patients.
RESULTS: The prevalence of hepatitis C antibody in haemophilic patients was 80%.
CONCLUSION: The study concludes that its incidence is certainly high for which necessary steps are required to be taken but the results of ALT (Alanine Aminotransferase) clearly conclude that ALT can not be used as a surrogate marker for hepatitis C infection. Anti-HCV antibody may relatively be an expensive test but according to this study ALT as a surrogate marker for hepatitis could not replace it, because we could not establish a good correlation between hepatitis C positivity and elevated ALT levels.
Keywords: Haemophilic, Hepatitis C, HCV, ALT.
